ClinicalTrials.Veeva

Menu

Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults

Lilly logo

Lilly

Status

Completed

Conditions

Depression
Suicide

Study type

Observational

Funder types

Industry

Identifiers

NCT00763724
12016
F1J-MC-B027

Details and patient eligibility

About

The primary objective of the study is to estimate the incidence of suicide attempts resulting in a medical encounter or hospitalization in seven propensity matched cohorts of subjects: patients treated with duloxetine for depression, patients treated with one of three other antidepressants or antidepressant classes (venlafaxine, SSRIs, or TCAs) for depression, patients treated with multiple antidepressants for depression (either concurrently or consecutively), depressed patients with no pharmacologic treatment, and a non-depressed general population sample.

Enrollment

254,432 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or older at index date
  • Have at least 6 months of continuous enrollment data prior to index date.
  • Have complete medical, facility, and pharmacy records (the latter of which will include complete quantity and days supplied information).

Exclusion criteria

  • None

Trial design

254,432 participants in 7 patient groups

1
Description:
Duloxetine
2
Description:
Venlafaxine
3
Description:
SSRI
4
Description:
TCA
5
Description:
Multiple Antidepressants
6
Description:
Depressed (not antidepressant treated)
7
Description:
General population

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems